Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mipsagargin in advanced hepatocellular carcinoma
NCT01777594Phase 2Completed
- Sponsor
- Inspyr Therapeutics
- Start
- Jan 2013
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
A Phase 2 trial of mipsagargin in hepatocellular carcinoma (HCC), sponsored by Inspyr Therapeutics. Started Jan 2013; status: completed.
02
Drugs
mipsagargin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01777594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777594.